Officials Eye New Biotech Tenants for Bristol-Myers' Former Connecticut Complex Post author:Sam Post published:February 15, 2018 Post category:BioPharma This week MA-based real estate firm Calare Properties acquired the land and buildings for $5M. Source: BioSpace You Might Also Like After a Billion+ Loss to Alzheimer's at Medivation, Takes Another Shot at Axovant September 6, 2017 Teva Makes Move to Block Eli Lilly From Bringing Its Migraine Drug to the U.S. October 25, 2017 New Study Assesses The Utility Of Masimo PVi Monitoring During Colorectal Surgery February 26, 2017